RTI Biologics Announces 2013 First Quarter Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the first quarter of 2013 as follows:

•Achieved quarterly revenues of $40.4 million.

•Achieved net income of $1.5 million, or $0.03 per fully diluted share.

Back to news